Tag : Biosciences

Latest News

LG Chem Life Sciences and TransThera Biosciences Announce License Agreement for Potential Treatment of NASH and Other Chronic Inflammatory Conditions

Newsemia
SEOUL, South Korea & NANJING, China–(BUSINESS WIRE)– #NASH–LG Chem enters an exclusive license agreement with TransThera for development and commercialization of TransThera’s TT-01025. Source link...
Biology

DuPont Nutrition & Biosciences Announces New Distribution Partnership with Interdisp JCS

Newsemia
WILMINGTON, Del. (PRWEB) May 12, 2020 DuPont Nutrition & Biosciences (N&B) has announced the selection of Interdisp JCS as the new distribution partner for all...
Biology

RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the Clinic

Newsemia
FREDERICK, Md. (PRWEB) March 17, 2020 RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti)...
Biology

Major Infant Health Collaboration Announced by APC Microbiome Ireland with DuPont Nutrition & Biosciences

Newsemia
WILMINGTON, Del. (PRWEB) March 12, 2020 Today, DuPont Nutrition & Biosciences (DuPont) announced a second collaboration with the APC Microbiome Ireland SFI Research Center (APC),...
Biology

ABCT, Connecticut’s Newest Accelerator Program for Biosciences Ventures, Announces 2020 Cohort of Life Science Startups

Newsemia
BRANFORD, Conn. (PRWEB) January 06, 2020 ABCT , the Accelerator for Biosciences in Connecticut, today announced the second cohort of emerging biosciences ventures invited to...
Latest News

Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate VE800 In Combination with Bristol-Myers Squibb’s Opdivo® (Nivolumab)

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate In Combination with Bristol-Myers Squibb’s Opdivo Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy